GLP-1 Weight Loss Calculator
Model your expected weight loss journey on semaglutide or tirzepatide with dose escalation timeline and cost estimates.
Related Articles
Tracking Your Response to a Triple Agonist: What the TRIUMPH-1 Numbers Suggest You Should Be LoggingPhase 3 TRIUMPH-1 reported 28.3% mean weight loss on retatrutide at 12 mg over 80 weeks, and ~19% on the new 4 mg low-dose arm. If your clinician puts you on a GLP-1 or triple agonist, here's what to track so you know whether the response is on-curve or off.Read article →Tracking Joint Pain on a GLP-1 or Triple Agonist: What the TRIUMPH-4 Data Suggests You Should Be LoggingPhase 3 TRIUMPH-4 reported a 75.8% reduction in WOMAC knee pain alongside 28.7% weight loss on retatrutide. If your clinician prescribes a GLP-1 or triple agonist, here's what to track to know whether your knees are actually responding.Read article →Best Apps for Tracking Strength While Running a Supplement ProtocolIf you log creatine, ashwagandha, or a structured stack, your lifting tracker has a different job than a generic logger. We compare LiftProof, Hevy, and Strong on tracking depth, privacy posture, and long-term export.Read article →
Track this daily — app coming soon
We're building Prova to log your GLP-1 progress data and surface automatic insights. Get notified when it launches.